HEXAGON70.11

Hexagon Nutrition Limited

· Pharma & Health
AnnualQuarterly₹ CroreMcap ₹776 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations115.0104.3
Other Income4.02.1
Total Income119.0106.4
Expenses
+ Cost of Materials Consumed55.367.1
+ Purchases of Stock-in-Trade0.01.3
+ Changes in Inventories9.3-9.8
+ Employee Benefit Expense14.413.6
+ Finance Costs1.11.0
+ Depreciation & Amortisation2.72.3
+ Other Expenses21.020.5
Total Expenses103.995.8
EBITDA15.111.7
EBIT12.39.4
Profit
PBT before Exceptional Items15.110.5
+ Exceptional Items0.30.1
Pretax Income15.410.6
+ Current Tax4.43.8
+ Deferred Tax0.1-1.3
Tax Expense4.52.5
Net Income10.98.1
+ Net Income — Continuing Ops10.98.1
+ Other Comprehensive Income0.80.4
Total Comprehensive Income11.78.4
Net Income to Common10.98.1
Per Share
Basic EPS0.990.67
Diluted EPS0.890.66
Other Comprehensive Income — detail
+ Other Comprehensive Income0.80.4
+ Items NOT to be Reclassified to P&L0.80.1
+ Tax on Items NOT to be Reclassified0.00.0
+ Items to be Reclassified to P&L0.3
Comprehensive Income — Owners of Parent0.80.4
Per Share — as-filed variants
Basic EPS — Continuing Operations0.990.67
Diluted EPS — Continuing Operations0.890.66
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit50.545.8
Gross Margin %43.8743.91
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)15.110.5
− Exceptional Items (reconciliation)0.30.1
Net Income Adj (tax-effected)10.78.0
EPS Adj0.970.67
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.00
Paid Up Equity Capital11.112.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.